Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Submitted by
admin
on December 2, 2014 - 9:00am
Source:
Bidness Etc.
News Tags:
Sanofi
FDA
Priftin
tuberculosis
Headline:
Sanofi SA (SNY) Gets FDA Nod For Priftin Tablets To Treat Latent TB Infection
Do Not Allow Advertisers to Use My Personal information
